|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Family-Owned Kent Pharmaceutical Holdings Sold in $77 Million Deal
1/14/2013 7:54:59 AM
A family-owned drugs firm has been sold in a £58 million deal. Kent Pharmaceuticals Holdings Limited (KPHL), based in Orbital Park, Ashford, is now part of DCC Healthcare after its acquisition by its DCC Vital subsidiary. Kent law firm Brachers played a key role the transaction, advising the majority shareholders in one of the largest deals handled by the firm in 2012. Kent Pharmaceuticals is a family business set up in the early 1980s. It went on to become Britain’s largest independent generic pharmaceuticals manufacturer and leading wholesaler. It is involved in the development, manufacture, sales, marketing and distribution of generic products for the British, Irish and international markets. It offers more than 100 own label products, with a manufacturing plant in Ireland supplying the UK with some 60% of the total penicillin antibiotics sold. DCC Vital, a healthcare services business, provides sales, marketing and distribution services in Ireland and Britain to healthcare providers, medical and pharmaceutical brand owners and manufacturers. DCC Plc is based in Ireland with a workforce of 9,000. DCC plans to combine the Kent business to create a pharmaceuticals business with combined turnover of around £123 million. A spokesman said there were plans for expansion which could involve more jobs.
|
|
|
|
|
|
|
|
|
|
|